168 related articles for article (PubMed ID: 26220525)
1. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P
J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525
[TBL] [Abstract][Full Text] [Related]
2. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.
Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C
J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
[TBL] [Abstract][Full Text] [Related]
4. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
[TBL] [Abstract][Full Text] [Related]
5. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.
Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J
Gene; 2020 Oct; 757():144938. PubMed ID: 32640305
[TBL] [Abstract][Full Text] [Related]
6. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
[TBL] [Abstract][Full Text] [Related]
7. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
[TBL] [Abstract][Full Text] [Related]
9. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation.
Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G
Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507
[TBL] [Abstract][Full Text] [Related]
10. A novel compound heterozygous mutation of
Zhan X; Zhao A; Wu B; Yang Y; Wan L; Tan P; Huang J; Lu Y
Br J Biomed Sci; 2021 Oct; 78(4):239-243. PubMed ID: 33618624
[No Abstract] [Full Text] [Related]
11. Control of B cell development by the histone H2A deubiquitinase MYSM1.
Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY
Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041
[TBL] [Abstract][Full Text] [Related]
12. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
[TBL] [Abstract][Full Text] [Related]
13. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
Petrov JC; Nijnik A
Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
[TBL] [Abstract][Full Text] [Related]
14. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation.
Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY
Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1.
Jiang XX; Chou Y; Jones L; Wang T; Sanchez S; Huang XF; Zhang L; Wang C; Chen SY
Sci Rep; 2015 Sep; 5():13755. PubMed ID: 26348977
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional differences of SWIRM domain subtypes.
Yoneyama M; Tochio N; Umehara T; Koshiba S; Inoue M; Yabuki T; Aoki M; Seki E; Matsuda T; Watanabe S; Tomo Y; Nishimura Y; Harada T; Terada T; Shirouzu M; Hayashizaki Y; Ohara O; Tanaka A; Kigawa T; Yokoyama S
J Mol Biol; 2007 May; 369(1):222-38. PubMed ID: 17428495
[TBL] [Abstract][Full Text] [Related]
17. Expression of MYSM1 is associated with tumor progression in colorectal cancer.
Li Y; Li J; Liu H; Liu Y; Cui B
PLoS One; 2017; 12(5):e0177235. PubMed ID: 28498834
[TBL] [Abstract][Full Text] [Related]
18. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation.
Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A
Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548
[TBL] [Abstract][Full Text] [Related]
19. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks.
Mathias B; O'Leary D; Saucier N; Ahmad F; White LS; Russell L; Shinawi M; Smith MJ; Abraham RS; Cooper MA; Kitcharoensakkul M; Green AM; Bednarski JJ
J Allergy Clin Immunol; 2024 Apr; 153(4):1113-1124.e7. PubMed ID: 38065233
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
